Table 3 |
|||||
|
Stratified analysis of rs729749 in men |
|||||
| Antibody status |
Case/control |
Genotypes |
P |
||
|
|
|||||
| CC |
CT |
TT |
|||
|
|
|||||
| RF positive |
Case |
0.68 (169) |
0.29 (71) |
0.03 (7) |
0.0713 |
| Control |
0.58 (170) |
0.37 (108) |
0.04 (11) |
||
| RF negative |
Case |
0.71 (87) |
0.20 (24) |
0.09 (11) |
0.0002 |
| Control |
0.57 (141) |
0.40 (98) |
0.04 (9) |
||
| Anti-CCP positive |
Case |
0.69 (159) |
0.28 (63) |
0.03 (7) |
0.0398 |
| Control |
0.59 (167) |
0.38 (107) |
0.04 (11) |
||
| Anti-CCP negative |
Case |
0.70 (97) |
0.22 (31) |
0.08 (11) |
0.0032 |
| Control |
0.59 (167) |
0.38 (107) |
0.04 (11) |
||
|
|
|||||
|
CCP, cyclic citrullinated peptide; RF, rheumatoid factor. Values indicate the genotype frequencies and number (in brackets). |
|||||
|
Olsson et al. Arthritis Research & Therapy 2007 9:R98 doi:10.1186/ar2299 |
|||||
